Patent Assignment
Reel/Frame 068204/0441
Change of Name
Recorded: 2024-08-07
Pages: 9
Assignor
SHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
Executed: 2024-06-24
Assignee
LEADINGTAC PHARMACEUTICAL (SHAOXING) CO., LTD.
SUITE 1001, BUILDING 9, DONGSHENG HUIGU INDUSTRIAL PARK, 1299 KEHAI AVENUE, ANCHANG STREET, KEQIAO DISTRICT, SHAOXING, CHINA
Covered Properties
(3)
Compound for Targeting and Degrading Protein, and Preparation Method Therefor and Use Thereof
Application:
17/999,798 →
Publication:
US 2023/0234936
Indazole Derivative, and Preparation Method Therefor and Use Thereof
Application:
18/000,205 →
Publication:
US 2023/0192655
Use of IRAK4 Inhibitor in Treatment of Acute Lung Injury Ali/Ards
Application:
17/996,734 →
Publication:
US 2023/0210833
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 20, 2022
From: FENG, YAN
To: SHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
Reel/Frame 061486/0313 →
Assignment of Assignor's Interest
Nov 23, 2022
From: FENG, YAN; LI, SHIQIANG
To: SHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
Reel/Frame 061868/0414 →
Assignment of Assignor's Interest
Nov 29, 2022
From: FENG, YAN; LI, SHIQIANG
To: SHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
Reel/Frame 061909/0342 →